Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global mRNA Vaccines & Therapeutics market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global mRNA Vaccines & Therapeutics market segmented into
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
Based on the end-use, the global mRNA Vaccines & Therapeutics market classified into
Hospital
Clinic
Others
Based on geography, the global mRNA Vaccines & Therapeutics market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Argos Therapeutics
AstraZeneca
Bayer
BioNTech
Boehringer Ingelheim
CRISPR Therapeutics
CureVac
eTheRNA immunotherapies
Ethris
GlaxoSmithKline Vaccines
In-Cell-Art
Intellia Therapeutics
Janssen
Kernal Biologics
MaxCyte
Moderna Therapeutics
Novartis
PhaseRx
Precision NanoSystems
RaNa Therapeutics
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL MRNA VACCINES & THERAPEUTICS INDUSTRY
2.1 Summary about mRNA Vaccines & Therapeutics Industry
2.2 mRNA Vaccines & Therapeutics Market Trends
2.2.1 mRNA Vaccines & Therapeutics Production & Consumption Trends
2.2.2 mRNA Vaccines & Therapeutics Demand Structure Trends
2.3 mRNA Vaccines & Therapeutics Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Standardization Of Cancer Treatment MRNA Vaccine
4.2.2 Individualized Cancer Treatment MRNA Vaccine
4.2.3 Infectious Disease Treatment MRNA Vaccine
4.2.4 Infection Prevention MRNA Vaccine
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital
4.3.2 Clinic
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Standardization Of Cancer Treatment MRNA Vaccine
5.2.2 Individualized Cancer Treatment MRNA Vaccine
5.2.3 Infectious Disease Treatment MRNA Vaccine
5.2.4 Infection Prevention MRNA Vaccine
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital
5.3.2 Clinic
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Standardization Of Cancer Treatment MRNA Vaccine
6.2.2 Individualized Cancer Treatment MRNA Vaccine
6.2.3 Infectious Disease Treatment MRNA Vaccine
6.2.4 Infection Prevention MRNA Vaccine
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital
6.3.2 Clinic
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Standardization Of Cancer Treatment MRNA Vaccine
7.2.2 Individualized Cancer Treatment MRNA Vaccine
7.2.3 Infectious Disease Treatment MRNA Vaccine
7.2.4 Infection Prevention MRNA Vaccine
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital
7.3.2 Clinic
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Standardization Of Cancer Treatment MRNA Vaccine
8.2.2 Individualized Cancer Treatment MRNA Vaccine
8.2.3 Infectious Disease Treatment MRNA Vaccine
8.2.4 Infection Prevention MRNA Vaccine
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital
8.3.2 Clinic
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Standardization Of Cancer Treatment MRNA Vaccine
9.2.2 Individualized Cancer Treatment MRNA Vaccine
9.2.3 Infectious Disease Treatment MRNA Vaccine
9.2.4 Infection Prevention MRNA Vaccine
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital
9.3.2 Clinic
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Argos Therapeutics
10.1.2 AstraZeneca
10.1.3 Bayer
10.1.4 BioNTech
10.1.5 Boehringer Ingelheim
10.1.6 CRISPR Therapeutics
10.1.7 CureVac
10.1.8 eTheRNA immunotherapies
10.1.9 Ethris
10.1.10 GlaxoSmithKline Vaccines
10.1.11 In-Cell-Art
10.1.12 Intellia Therapeutics
10.1.13 Janssen
10.1.14 Kernal Biologics
10.1.15 MaxCyte
10.1.16 Moderna Therapeutics
10.1.17 Novartis
10.1.18 PhaseRx
10.1.19 Precision NanoSystems
10.1.20 RaNa Therapeutics
10.2 mRNA Vaccines & Therapeutics Sales Date of Major Players (2017-2020e)
10.2.1 Argos Therapeutics
10.2.2 AstraZeneca
10.2.3 Bayer
10.2.4 BioNTech
10.2.5 Boehringer Ingelheim
10.2.6 CRISPR Therapeutics
10.2.7 CureVac
10.2.8 eTheRNA immunotherapies
10.2.9 Ethris
10.2.10 GlaxoSmithKline Vaccines
10.2.11 In-Cell-Art
10.2.12 Intellia Therapeutics
10.2.13 Janssen
10.2.14 Kernal Biologics
10.2.15 MaxCyte
10.2.16 Moderna Therapeutics
10.2.17 Novartis
10.2.18 PhaseRx
10.2.19 Precision NanoSystems
10.2.20 RaNa Therapeutics
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
Table mRNA Vaccines & Therapeutics Product Type Overview
Table mRNA Vaccines & Therapeutics Product Type Market Share List
Table mRNA Vaccines & Therapeutics Product Type of Major Players
Table Brief Introduction of Argos Therapeutics
Table Brief Introduction of AstraZeneca
Table Brief Introduction of Bayer
Table Brief Introduction of BioNTech
Table Brief Introduction of Boehringer Ingelheim
Table Brief Introduction of CRISPR Therapeutics
Table Brief Introduction of CureVac
Table Brief Introduction of eTheRNA immunotherapies
Table Brief Introduction of Ethris
Table Brief Introduction of GlaxoSmithKline Vaccines
Table Brief Introduction of In-Cell-Art
Table Brief Introduction of Intellia Therapeutics
Table Brief Introduction of Janssen
Table Brief Introduction of Kernal Biologics
Table Brief Introduction of MaxCyte
Table Brief Introduction of Moderna Therapeutics
Table Brief Introduction of Novartis
Table Brief Introduction of PhaseRx
Table Brief Introduction of Precision NanoSystems
Table Brief Introduction of RaNa Therapeutics
Table Products & Services of Argos Therapeutics
Table Products & Services of AstraZeneca
Table Products & Services of Bayer
Table Products & Services of BioNTech
Table Products & Services of Boehringer Ingelheim
Table Products & Services of CRISPR Therapeutics
Table Products & Services of CureVac
Table Products & Services of eTheRNA immunotherapies
Table Products & Services of Ethris
Table Products & Services of GlaxoSmithKline Vaccines
Table Products & Services of In-Cell-Art
Table Products & Services of Intellia Therapeutics
Table Products & Services of Janssen
Table Products & Services of Kernal Biologics
Table Products & Services of MaxCyte
Table Products & Services of Moderna Therapeutics
Table Products & Services of Novartis
Table Products & Services of PhaseRx
Table Products & Services of Precision NanoSystems
Table Products & Services of RaNa Therapeutics
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global mRNA Vaccines & Therapeutics Market Forecast (Million USD) by Region 2021f-2026f
Table Global mRNA Vaccines & Therapeutics Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global mRNA Vaccines & Therapeutics Market Forecast (Million USD) by Demand 2021f-2026f
Table Global mRNA Vaccines & Therapeutics Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global mRNA Vaccines & Therapeutics Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global mRNA Vaccines & Therapeutics Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global mRNA Vaccines & Therapeutics Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global mRNA Vaccines & Therapeutics Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global mRNA Vaccines & Therapeutics Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global mRNA Vaccines & Therapeutics Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global mRNA Vaccines & Therapeutics Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Standardization Of Cancer Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Individualized Cancer Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Infectious Disease Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Infection Prevention MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Standardization Of Cancer Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Individualized Cancer Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Infectious Disease Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Infection Prevention MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Standardization Of Cancer Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Individualized Cancer Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Infectious Disease Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Infection Prevention MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Standardization Of Cancer Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Individualized Cancer Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Infectious Disease Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Infection Prevention MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Standardization Of Cancer Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Individualized Cancer Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Infectious Disease Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Infection Prevention MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Standardization Of Cancer Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Individualized Cancer Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Infectious Disease Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Infection Prevention MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of Argos Therapeutics 2017-2020e
Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of AstraZeneca 2017-2020e
Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of Bayer 2017-2020e
Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of BioNTech 2017-2020e
Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of Boehringer Ingelheim 2017-2020e
Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of CRISPR Therapeutics 2017-2020e
Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of CureVac 2017-2020e
Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of eTheRNA immunotherapies 2017-2020e
Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of Ethris 2017-2020e
Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of GlaxoSmithKline Vaccines 2017-2020e
Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of In-Cell-Art 2017-2020e
Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of Intellia Therapeutics 2017-2020e
Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of Janssen 2017-2020e
Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of Kernal Biologics 2017-2020e
Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of MaxCyte 2017-2020e
Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of Moderna Therapeutics 2017-2020e
Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of Novartis 2017-2020e
Figure Sales Revenue (Million USD) of PhaseRx 2017-2020e
Figure Sales Revenue (Million USD) of Precision NanoSystems 2017-2020e
Figure Sales Revenue (Million USD) of RaNa Therapeutics 2017-2020e